Recent trials support a long-lasting efficacy of renal denervation in lowering blood pressure in patients with resistant hypertension as an adjunct to conventional drug- and lifestyle-based treatment.

The new devices for renal denervation available on the market generate more thorough ablation patterns and thereby ensure an efficient procedure.

Adaption of the clinical guidelines to the new scientific evidence has already started, and renal denervation might play an important role in the future management of arterial hypertension.